跳至主要内容
临床试验/NCT00597311
NCT00597311Unknown3 期

Preoperative Chemoradiation Versus Short Term Radiation Alone With Delayed Surgery for Stage II and III Resectable Rectal Cancer

Kaunas University of Medicine1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2007年1月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
入组人数
150
试验地点
1
主要终点
5 years overall and disease free survival

研究概览

简要总结

Trial compares two preoperative stage II and III rectal cancer treatment strategies: short term radiotherapy 5x5 Gy and delayed surgery after 6 weeks versus conventional chemoradiotherapy 50 Gy + 5Fu/Lv and surgery also after 6 weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •histologically confirmed stage II and III rectal cancer less than 15 cm from anal verge
  • •less than 80 years old
  • •no other cancer during 5 years period
  • •compensate cardiovascular, pulmonary, hepatic and renal functions.

排除标准

  • •stage I or IV rectal cancer
  • •other cancer in 5 years period
  • •radiotherapy or chemotherapy in anamnesis
  • •not compensate cardiovascular, pulmonary, hepatic or renal functions, neurological, psychiatric disease, sepsis, etc.
  • •pregnancy or baby feeding

研究组 & 干预措施

1

Experimental

preoperative short term radiation group 5x5 Gy and surgery after 6 weeks

干预措施: radiotherapy (Radiation)

2

Experimental

preoperative chemoradiotherapy group 50Gy + 5FU/Lv and surgery after 6 weeks.

干预措施: radiotherapy (Radiation)

结局指标

主要结局

5 years overall and disease free survival

时间窗: 5 years

recurrence rate

时间窗: 5 years

次要结局

  • pathological "complete response" and downstaging rates(5 years)
  • Impact on sphincter sparing operation rates(5 years)
  • morbidity and mortality rates(5 years)
  • Impact on quality of surgical resection(5 years)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验